event
< (From left) KAIST President Kwang-Hyung Lee and Merck CEO Matthias Heinzel >
KAIST (President Kwang-Hyung Lee) signed a Memorandum of Understanding (MOU) with Merck Life Science (CEO Matthias Heinzel) on May 29 to foster innovation and technology creation in advanced biotechnology.
Since May of last year, the two institutions have been discussing multidimensional innovation programs and will now focus on industry-academia cooperation to tackle bioindustry challenges with this MOU as a foundation.
KAIST will conduct joint research projects in various advanced biotechnology fields, such as synthetic biology, mRNA, cell line engineering, and organoids, using the chemical and biological portfolios provided by Merck.
Additionally, KAIST will establish an Experience Lab in collaboration with the Department of Materials Science and Engineering and the Graduate School of Medical Science and Engineering. This lab will support the discovery and analysis of candidate substances in materials science and biology.
Programs to enhance researchers' capabilities will also be offered. Scholarships for graduate students and awards for professors will be implemented. Researchers will have opportunities to participate in global academic events and educational programs hosted by Merck, such as the Curious 2024 Future Insight Conference and the Innovation Cup.
M Ventures, a venture capital subsidiary of Merck Group, will collaborate with KAIST's startup institute to support technology commercialization and continue to develop their startup ecosystem.
The signing ceremony at KAIST's main campus in Daejeon was attended by the CEO of Merck Life Science and the President of KAIST along with representatives from both institutions.
Matthias Heinzel, a member of the Executive Board of Merck and CEO Life Science, said, “This agreement with KAIST is a significant step toward accelerating the development of the life science industry both in Korea and globally. Advancing life science research and fostering the next generation of scientists is essential for discovering new medicines to meet global health needs.”
President Kwang-Hyung Lee responded, “We are pleased to share a vision for scientific advancement with Merck, a leading global technology company. We anticipate that this partnership will strengthen the connection between Merck’s life science business and the global scientific community.”
In March, Merck, a global science and technology company with over 350 years of history, announced a plan to invest 430 billion KRW (€300 million) to build a bioprocessing center in Daejeon, where KAIST is located. This is Merck's largest investment in the Asia-Pacific region.
-
event KAIST VIRNECT Sign Agreement to Establish Virtual Convergence Research Center
< (From left) Tae Jin Ha, CEO of VIRNECT, Kwang Hyung Lee, President of KAIST > An open platform for industry-academia-research collaboration, which has accumulated K-Metaverse technology capabilities that break down the boundaries between reality and virtuality and share experiences beyond the limits of time and space, is expected to be built on our university campus. Our university announced on the 13th that it’s signing an agreement for the establishment and operation of a 'Vi
2025-10-13 -
event Mobility 2025 Technology Demonstration Day Held... Commercialization Achievements Unveiled
< Kitae Jang, Director of Mobility Research Institute, Hyeong-sik Jeon, Vice Governor for Political Affairs of South Chungcheong Province and demonstration officials > KAIST's e announced on the September 23rd that it held the "2025 Technology Demonstration Day" at the Naepo Knowledge Industry Center in Chungcheongnam-do to showcase successful cases of its research findings being adopted by the industry. The event was organized to present the process of commercializing KAIST's ac
2025-09-24 -
research Material Innovation Realized with Robotic Arms and AI, Without Human Researchers
<(From Left) M.S candidate Dongwoo Kim from KAIST, Ph.D candidate Hyun-Gi Lee from KAIST, Intern Yeham Kang from KAIST, M.S candidate Seongjae Bae from KAIST, Professor Dong-Hwa Seo from KAIST, (From top right, from left) Senior Researcher Inchul Park from POSCO Holdings, Senior Researcher Jung Woo Park, senior researcher from POSCO Holdings> A joint research team from industry and academia in Korea has successfully developed an autonomous lab that uses AI and automation to create ne
2025-08-06 -
research RAIBO Runs over Walls with Feline Agility... Ready for Effortless Search over Mountaineous and Rough Terrains
< Photo 1. Research Team Photo (Professor Jemin Hwangbo, second from right in the front row) > KAIST's quadrupedal robot, RAIBO, can now move at high speed across discontinuous and complex terrains such as stairs, gaps, walls, and debris. It has demonstrated its ability to run on vertical walls, leap over 1.3-meter-wide gaps, sprint at approximately 14.4 km/h over stepping stones, and move quickly and nimbly on terrain combining 30° slopes, stairs, and stepping stones. RAIBO is ex
2025-06-04 -
research Professor Hyun Myung's Team Wins First Place in a Challenge at ICRA by IEEE
< Photo 1. (From left) Daebeom Kim (Team Leader, Ph.D. student), Seungjae Lee (Ph.D. student), Seoyeon Jang (Ph.D. student), Jei Kong (Master's student), Professor Hyun Myung > A team of the Urban Robotics Lab, led by Professor Hyun Myung from the KAIST School of Electrical Engineering, achieved a remarkable first-place overall victory in the Nothing Stands Still Challenge (NSS Challenge) 2025, held at the 2025 IEEE International Conference on Robotics and Automation (ICRA), the world
2025-05-30